 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0052871	alpha-tocopherol omega-hydroxylase activity	1	9.749666e-5	3.595677e-1	3.595677e-1	1.025676e+4	9.749666e-5	1	9.749666e-5	1.000000e+0	6	2.217111e-4	8.176705e-1	1.362784e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	CYP4F3
GO Molecular Function	GO:0050051	leukotriene-B4 20-monooxygenase activity	2	1.931819e-4	7.124548e-1	3.562274e-1	5.176467e+3	1.931819e-4	1	1.931819e-4	1.000000e+0	7	4.433975e-4	1.000000e+0	2.336071e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	CYP4F3
GO Molecular Function	GO:0016709	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen	3	2.774056e-3	1.000000e+0	1.000000e+0	3.604830e+2	2.774056e-3	1	2.774056e-3	1.000000e+0	9	4.318932e-3	1.000000e+0	1.000000e+0	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	CYP4F3
GO Molecular Function	GO:0004497	monooxygenase activity	4	7.515851e-3	1.000000e+0	1.000000e+0	1.330521e+2	7.515851e-3	1	7.515851e-3	1.000000e+0	1	2.861184e-5	1.055205e-1	1.055205e-1	1.859897e+2	1.075328e-2	2	97	1.000000e+0	2.061856e-2	unnamed	CYP4F22,CYP4F3
GO Molecular Function	GO:0020037	heme binding	5	8.778443e-3	1.000000e+0	1.000000e+0	1.139154e+2	8.778443e-3	1	8.778443e-3	1.000000e+0	2	5.073440e-5	1.871085e-1	9.355423e-2	1.398527e+2	1.430076e-2	2	129	1.000000e+0	1.550388e-2	unnamed	CYP4F22,CYP4F3
GO Molecular Function	GO:0046906	tetrapyrrole binding	6	9.836374e-3	1.000000e+0	1.000000e+0	1.016635e+2	9.836374e-3	1	9.836374e-3	1.000000e+0	3	5.809015e-5	2.142365e-1	7.141216e-2	1.307319e+2	1.529849e-2	2	138	1.000000e+0	1.449275e-2	unnamed	CYP4F22,CYP4F3
GO Molecular Function	GO:0005506	iron ion binding	7	1.254896e-2	1.000000e+0	1.000000e+0	7.968786e+1	1.254896e-2	1	1.254896e-2	1.000000e+0	5	7.914960e-5	2.919037e-1	5.838074e-2	1.120559e+2	1.784823e-2	2	161	1.000000e+0	1.242236e-2	unnamed	CYP4F22,CYP4F3
GO Molecular Function	GO:0016705	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	8	1.379212e-2	1.000000e+0	1.000000e+0	7.250518e+1	1.379212e-2	1	1.379212e-2	1.000000e+0	4	7.621836e-5	2.810933e-1	7.027333e-2	1.141835e+2	1.751566e-2	2	158	1.000000e+0	1.265823e-2	unnamed	CYP4F22,CYP4F3
GO Molecular Function	GO:0016491	oxidoreductase activity	9	6.045513e-2	1.000000e+0	1.000000e+0	1.654119e+1	6.045513e-2	1	6.045513e-2	1.000000e+0	8	1.568582e-3	1.000000e+0	7.231163e-1	2.523217e+1	7.926390e-2	2	715	1.000000e+0	2.797203e-3	unnamed	CYP4F22,CYP4F3
GO Molecular Function	GO:0046914	transition metal ion binding	10	1.321251e-1	1.000000e+0	1.000000e+0	7.568583e+0	1.321251e-1	1	1.321251e-1	1.000000e+0	10	6.226124e-3	1.000000e+0	1.000000e+0	1.266924e+1	1.578626e-1	2	1424	1.000000e+0	1.404494e-3	unnamed	CYP4F22,CYP4F3
GO Molecular Function	GO:0046872	metal ion binding	11	3.527991e-1	1.000000e+0	1.000000e+0	2.834474e+0	3.527991e-1	1	3.527991e-1	1.000000e+0	11	4.826814e-2	1.000000e+0	1.000000e+0	4.551211e+0	4.394435e-1	2	3964	1.000000e+0	5.045409e-4	unnamed	CYP4F22,CYP4F3
GO Molecular Function	GO:0043169	cation binding	12	3.606111e-1	1.000000e+0	1.000000e+0	2.773071e+0	3.606111e-1	1	3.606111e-1	1.000000e+0	12	4.988904e-2	1.000000e+0	1.000000e+0	4.476675e+0	4.467602e-1	2	4030	1.000000e+0	4.962779e-4	unnamed	CYP4F22,CYP4F3
GO Molecular Function	GO:1901363	heterocyclic compound binding	13	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	13	8.629242e-2	1.000000e+0	1.000000e+0	3.403962e+0	5.875506e-1	2	5300	1.000000e+0	3.773585e-4	unnamed	CYP4F22,CYP4F3
GO Molecular Function	GO:0097159	organic cyclic compound binding	14	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	14	8.868613e-2	1.000000e+0	1.000000e+0	3.357714e+0	5.956433e-1	2	5373	1.000000e+0	3.722315e-4	unnamed	CYP4F22,CYP4F3
GO Molecular Function	GO:0003824	catalytic activity	15	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	15	9.272591e-2	1.000000e+0	1.000000e+0	3.283764e+0	6.090571e-1	2	5494	1.000000e+0	3.640335e-4	unnamed	CYP4F22,CYP4F3
GO Molecular Function	GO:0043167	ion binding	16	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	16	1.118514e-1	1.000000e+0	1.000000e+0	2.989891e+0	6.689208e-1	2	6034	1.000000e+0	3.314551e-4	unnamed	CYP4F22,CYP4F3
GO Molecular Function	GO:0005488	binding	17	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	17	4.553379e-1	1.000000e+0	1.000000e+0	1.481929e+0	1.349593e+0	2	12174	1.000000e+0	1.642845e-4	unnamed	CYP4F22,CYP4F3
GO Biological Process	GO:0036101	leukotriene B4 catabolic process	1	1.931819e-4	1.000000e+0	1.000000e+0	5.176467e+3	1.931819e-4	1	1.931819e-4	1.000000e+0	1	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	CYP4F3
GO Biological Process	GO:0042758	long-chain fatty acid catabolic process	2	2.714303e-4	1.000000e+0	1.000000e+0	3.684186e+3	2.714303e-4	1	2.714303e-4	1.000000e+0	2	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	CYP4F3
GO Biological Process	GO:0006691	leukotriene metabolic process	3	2.417056e-3	1.000000e+0	1.000000e+0	4.137265e+2	2.417056e-3	1	2.417056e-3	1.000000e+0	4	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	CYP4F3
GO Biological Process	GO:0019369	arachidonic acid metabolic process	4	3.329049e-3	1.000000e+0	1.000000e+0	3.003860e+2	3.329049e-3	1	3.329049e-3	1.000000e+0	5	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	CYP4F3
GO Biological Process	GO:0009062	fatty acid catabolic process	5	5.120350e-3	1.000000e+0	1.000000e+0	1.952992e+2	5.120350e-3	1	5.120350e-3	1.000000e+0	7	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	CYP4F3
GO Biological Process	GO:1901616	organic hydroxy compound catabolic process	6	5.386312e-3	1.000000e+0	1.000000e+0	1.856558e+2	5.386312e-3	1	5.386312e-3	1.000000e+0	6	6.751129e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	CYP4F3
GO Biological Process	GO:0006690	icosanoid metabolic process	7	5.508572e-3	1.000000e+0	1.000000e+0	1.815352e+2	5.508572e-3	1	5.508572e-3	1.000000e+0	8	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	CYP4F3
GO Biological Process	GO:0001676	long-chain fatty acid metabolic process	8	5.861454e-3	1.000000e+0	1.000000e+0	1.706061e+2	5.861454e-3	1	5.861454e-3	1.000000e+0	10	9.180352e-3	1.000000e+0	1.000000e+0	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	CYP4F3
GO Biological Process	GO:0033559	unsaturated fatty acid metabolic process	9	6.219924e-3	1.000000e+0	1.000000e+0	1.607737e+2	6.219924e-3	1	6.219924e-3	1.000000e+0	11	1.017327e-2	1.000000e+0	1.000000e+0	9.804891e+1	1.019899e-2	1	92	5.000000e-1	1.086957e-2	unnamed	CYP4F3
GO Biological Process	GO:0072329	monocarboxylic acid catabolic process	10	6.925624e-3	1.000000e+0	1.000000e+0	1.443913e+2	6.925624e-3	1	6.925624e-3	1.000000e+0	9	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	CYP4F3
GO Biological Process	GO:0044242	cellular lipid catabolic process	11	1.025236e-2	1.000000e+0	1.000000e+0	9.753854e+1	1.025236e-2	1	1.025236e-2	1.000000e+0	12	1.380970e-2	1.000000e+0	1.000000e+0	7.216400e+1	1.385732e-2	1	125	5.000000e-1	8.000000e-3	unnamed	CYP4F3
GO Biological Process	GO:0006805	xenobiotic metabolic process	12	1.071330e-2	1.000000e+0	1.000000e+0	9.334193e+1	1.071330e-2	1	1.071330e-2	1.000000e+0	13	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	CYP4F3
GO Biological Process	GO:0071466	cellular response to xenobiotic stimulus	13	1.074828e-2	1.000000e+0	1.000000e+0	9.303814e+1	1.074828e-2	1	1.074828e-2	1.000000e+0	14	1.721965e-2	1.000000e+0	1.000000e+0	5.782372e+1	1.729394e-2	1	156	5.000000e-1	6.410256e-3	unnamed	CYP4F3
GO Biological Process	GO:0009410	response to xenobiotic stimulus	14	1.166921e-2	1.000000e+0	1.000000e+0	8.569563e+1	1.166921e-2	1	1.166921e-2	1.000000e+0	15	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	CYP4F3
GO Biological Process	GO:0016042	lipid catabolic process	15	1.659167e-2	1.000000e+0	1.000000e+0	6.027120e+1	1.659167e-2	1	1.659167e-2	1.000000e+0	17	2.445986e-2	1.000000e+0	1.000000e+0	4.063288e+1	2.461061e-2	1	222	5.000000e-1	4.504505e-3	unnamed	CYP4F3
GO Biological Process	GO:0046395	carboxylic acid catabolic process	16	1.692589e-2	1.000000e+0	1.000000e+0	5.908109e+1	1.692589e-2	1	1.692589e-2	1.000000e+0	16	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	CYP4F3
GO Biological Process	GO:0044282	small molecule catabolic process	17	2.122837e-2	1.000000e+0	1.000000e+0	4.710678e+1	2.122837e-2	1	2.122837e-2	1.000000e+0	18	2.806993e-2	1.000000e+0	1.000000e+0	3.537451e+1	2.826894e-2	1	255	5.000000e-1	3.921569e-3	unnamed	CYP4F3
GO Biological Process	GO:0006631	fatty acid metabolic process	18	2.242543e-2	1.000000e+0	1.000000e+0	4.459223e+1	2.242543e-2	1	2.242543e-2	1.000000e+0	20	2.959946e-2	1.000000e+0	1.000000e+0	3.353346e+1	2.982096e-2	1	269	5.000000e-1	3.717472e-3	unnamed	CYP4F3
GO Biological Process	GO:0032787	monocarboxylic acid metabolic process	19	3.578238e-2	1.000000e+0	1.000000e+0	2.794672e+1	3.578238e-2	1	3.578238e-2	1.000000e+0	22	4.558673e-2	1.000000e+0	1.000000e+0	2.168389e+1	4.611718e-2	1	416	5.000000e-1	2.403846e-3	unnamed	CYP4F3
GO Biological Process	GO:1901615	organic hydroxy compound metabolic process	20	3.732400e-2	1.000000e+0	1.000000e+0	2.679241e+1	3.732400e-2	1	3.732400e-2	1.000000e+0	21	4.472009e-2	1.000000e+0	1.000000e+0	2.210907e+1	4.523031e-2	1	408	5.000000e-1	2.450980e-3	unnamed	CYP4F3
GO Biological Process	GO:0019752	carboxylic acid metabolic process	21	6.544102e-2	1.000000e+0	1.000000e+0	1.528093e+1	6.544102e-2	1	6.544102e-2	1.000000e+0	23	8.735845e-2	1.000000e+0	1.000000e+0	1.119169e+1	8.935203e-2	1	806	5.000000e-1	1.240695e-3	unnamed	CYP4F3
GO Biological Process	GO:0044255	cellular lipid metabolic process	22	7.113785e-2	1.000000e+0	1.000000e+0	1.405721e+1	7.113785e-2	1	7.113785e-2	1.000000e+0	24	8.894639e-2	1.000000e+0	1.000000e+0	1.098721e+1	9.101491e-2	1	821	5.000000e-1	1.218027e-3	unnamed	CYP4F3
GO Biological Process	GO:0055114	oxidation-reduction process	23	7.921377e-2	1.000000e+0	1.000000e+0	1.262407e+1	7.921377e-2	1	7.921377e-2	1.000000e+0	3	2.614782e-3	1.000000e+0	1.000000e+0	1.954605e+1	1.023225e-1	2	923	1.000000e+0	2.166847e-3	unnamed	CYP4F22,CYP4F3
GO Biological Process	GO:0043436	oxoacid metabolic process	24	8.179018e-2	1.000000e+0	1.000000e+0	1.222641e+1	8.179018e-2	1	8.179018e-2	1.000000e+0	25	9.918168e-2	1.000000e+0	1.000000e+0	9.826253e+0	1.017682e-1	1	918	5.000000e-1	1.089325e-3	unnamed	CYP4F3
GO Biological Process	GO:0006082	organic acid metabolic process	25	8.296012e-2	1.000000e+0	1.000000e+0	1.205398e+1	8.296012e-2	1	8.296012e-2	1.000000e+0	26	1.008644e-1	1.000000e+0	1.000000e+0	9.657923e+0	1.035419e-1	1	934	5.000000e-1	1.070664e-3	unnamed	CYP4F3
GO Biological Process	GO:0006629	lipid metabolic process	26	9.193917e-2	1.000000e+0	1.000000e+0	1.087676e+1	9.193917e-2	1	9.193917e-2	1.000000e+0	27	1.144784e-1	1.000000e+0	1.000000e+0	8.477914e+0	1.179536e-1	1	1064	5.000000e-1	9.398496e-4	unnamed	CYP4F3
GO Biological Process	GO:0044248	cellular catabolic process	27	1.236997e-1	1.000000e+0	1.000000e+0	8.084094e+0	1.236997e-1	1	1.236997e-1	1.000000e+0	28	1.690077e-1	1.000000e+0	1.000000e+0	5.655486e+0	1.768195e-1	1	1595	5.000000e-1	6.269592e-4	unnamed	CYP4F3
GO Biological Process	GO:1901575	organic substance catabolic process	28	1.333602e-1	1.000000e+0	1.000000e+0	7.498488e+0	1.333602e-1	1	1.333602e-1	1.000000e+0	29	1.828954e-1	1.000000e+0	1.000000e+0	5.205136e+0	1.921180e-1	1	1733	5.000000e-1	5.770340e-4	unnamed	CYP4F3
GO Biological Process	GO:0009056	catabolic process	29	1.498546e-1	1.000000e+0	1.000000e+0	6.673137e+0	1.498546e-1	1	1.498546e-1	1.000000e+0	31	2.035077e-1	1.000000e+0	1.000000e+0	4.649742e+0	2.150657e-1	1	1940	5.000000e-1	5.154639e-4	unnamed	CYP4F3
GO Biological Process	GO:0070887	cellular response to chemical stimulus	30	1.826020e-1	1.000000e+0	1.000000e+0	5.476391e+0	1.826020e-1	1	1.826020e-1	1.000000e+0	30	1.959705e-1	1.000000e+0	1.000000e+0	4.839324e+0	2.066404e-1	1	1864	5.000000e-1	5.364807e-4	unnamed	CYP4F3
GO Biological Process	GO:0044281	small molecule metabolic process	31	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	32	2.509628e-1	1.000000e+0	1.000000e+0	3.716728e+0	2.690538e-1	1	2427	5.000000e-1	4.120313e-4	unnamed	CYP4F3
GO Biological Process	GO:0044710	single-organism metabolic process	32	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	19	2.877979e-2	1.000000e+0	1.000000e+0	5.893826e+0	3.393382e-1	2	3061	1.000000e+0	6.533812e-4	unnamed	CYP4F22,CYP4F3
GO Biological Process	GO:0042221	response to chemical stimulus	33	2.954524e-1	1.000000e+0	1.000000e+0	3.384640e+0	2.954524e-1	1	2.954524e-1	1.000000e+0	34	3.326549e-1	1.000000e+0	1.000000e+0	2.731002e+0	3.661660e-1	1	3303	5.000000e-1	3.027551e-4	unnamed	CYP4F3
GO Biological Process	GO:0051716	cellular response to stimulus	34	4.562761e-1	1.000000e+0	1.000000e+0	2.191655e+0	4.562761e-1	1	4.562761e-1	1.000000e+0	35	5.039946e-1	1.000000e+0	1.000000e+0	1.690815e+0	5.914306e-1	1	5335	5.000000e-1	1.874414e-4	unnamed	CYP4F3
GO Biological Process	GO:0050896	response to stimulus	35	5.533212e-1	1.000000e+0	1.000000e+0	1.807268e+0	5.533212e-1	1	5.533212e-1	1.000000e+0	36	6.177696e-1	1.000000e+0	1.000000e+0	1.309787e+0	7.634832e-1	1	6887	5.000000e-1	1.452011e-4	unnamed	CYP4F3
GO Biological Process	GO:0044237	cellular metabolic process	36	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	37	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	CYP4F3
GO Biological Process	GO:0044238	primary metabolic process	37	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	38	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	CYP4F3
GO Biological Process	GO:0071704	organic substance metabolic process	38	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	39	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	CYP4F3
GO Biological Process	GO:0008152	metabolic process	39	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	33	2.598086e-1	1.000000e+0	1.000000e+0	1.961831e+0	1.019456e+0	2	9196	1.000000e+0	2.174859e-4	unnamed	CYP4F22,CYP4F3
GO Biological Process	GO:0044763	single-organism cellular process	40	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	40	8.068544e-1	1.000000e+0	1.000000e+0	8.920589e-1	1.121002e+0	1	10112	5.000000e-1	9.889241e-5	unnamed	CYP4F3
GO Biological Process	GO:0044699	single-organism process	41	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	41	8.529291e-1	1.000000e+0	1.000000e+0	8.110502e-1	1.232969e+0	1	11122	5.000000e-1	8.991189e-5	unnamed	CYP4F3
GO Biological Process	GO:0009987	cellular process	42	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	42	9.369062e-1	1.000000e+0	1.000000e+0	6.677400e-1	1.497589e+0	1	13509	5.000000e-1	7.402472e-5	unnamed	CYP4F3
GO Cellular Component	GO:0005789	endoplasmic reticulum membrane	1	6.490642e-2	1.000000e+0	1.000000e+0	1.540680e+1	6.490642e-2	1	6.490642e-2	1.000000e+0	1	1.900641e-3	1.000000e+0	1.000000e+0	2.292376e+1	8.724572e-2	2	787	1.000000e+0	2.541296e-3	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0042175	nuclear outer membrane-endoplasmic reticulum membrane network	2	6.714499e-2	1.000000e+0	1.000000e+0	1.489314e+1	6.714499e-2	1	6.714499e-2	1.000000e+0	2	1.993581e-3	1.000000e+0	1.000000e+0	2.238337e+1	8.935203e-2	2	806	1.000000e+0	2.481390e-3	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0044432	endoplasmic reticulum part	3	7.857548e-2	1.000000e+0	1.000000e+0	1.272662e+1	7.857548e-2	1	7.857548e-2	1.000000e+0	3	2.712041e-3	1.000000e+0	1.000000e+0	1.919255e+1	1.042071e-1	2	940	1.000000e+0	2.127660e-3	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0005783	endoplasmic reticulum	4	1.167593e-1	1.000000e+0	1.000000e+0	8.564628e+0	1.167593e-1	1	1.167593e-1	1.000000e+0	4	5.562502e-3	1.000000e+0	1.000000e+0	1.340342e+1	1.492157e-1	2	1346	1.000000e+0	1.485884e-3	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0012505	endomembrane system	5	1.513815e-1	1.000000e+0	1.000000e+0	6.605825e+0	1.513815e-1	1	1.513815e-1	1.000000e+0	5	8.319526e-3	1.000000e+0	1.000000e+0	1.096051e+1	1.824733e-1	2	1646	1.000000e+0	1.215067e-3	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0031090	organelle membrane	6	2.131131e-1	1.000000e+0	1.000000e+0	4.692344e+0	2.131131e-1	1	2.131131e-1	1.000000e+0	6	2.034938e-2	1.000000e+0	1.000000e+0	7.008936e+0	2.853500e-1	2	2574	1.000000e+0	7.770008e-4	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0016021	integral to membrane	7	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	18	4.982001e-1	1.000000e+0	1.000000e+0	1.714598e+0	5.832271e-1	1	5261	5.000000e-1	1.900779e-4	unnamed	CYP4F3
GO Cellular Component	GO:0031224	intrinsic to membrane	8	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	20	5.070350e-1	1.000000e+0	1.000000e+0	1.678545e+0	5.957541e-1	1	5374	5.000000e-1	1.860811e-4	unnamed	CYP4F3
GO Cellular Component	GO:0044446	intracellular organelle part	9	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	8	1.292379e-1	1.000000e+0	1.000000e+0	2.781529e+0	7.190289e-1	2	6486	1.000000e+0	3.083565e-4	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0044422	organelle part	10	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	9	1.337401e-1	1.000000e+0	1.000000e+0	2.734313e+0	7.314450e-1	2	6598	1.000000e+0	3.031222e-4	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0044444	cytoplasmic part	11	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	10	1.519576e-1	1.000000e+0	1.000000e+0	2.565193e+0	7.796685e-1	2	7033	1.000000e+0	2.843737e-4	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0044425	membrane part	12	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	7	1.178243e-1	1.000000e+0	1.000000e+0	2.913128e+0	6.865473e-1	2	6193	1.000000e+0	3.229453e-4	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0016020	membrane	13	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	11	1.895088e-1	1.000000e+0	1.000000e+0	2.297046e+0	8.706834e-1	2	7854	1.000000e+0	2.546473e-4	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0005737	cytoplasm	14	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	12	2.746502e-1	1.000000e+0	1.000000e+0	1.908091e+0	1.048168e+0	2	9455	1.000000e+0	2.115283e-4	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	15	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	13	3.079649e-1	1.000000e+0	1.000000e+0	1.801938e+0	1.109916e+0	2	10012	1.000000e+0	1.997603e-4	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0043227	membrane-bounded organelle	16	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	14	3.100602e-1	1.000000e+0	1.000000e+0	1.795839e+0	1.113685e+0	2	10046	1.000000e+0	1.990842e-4	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0043229	intracellular organelle	17	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	15	3.712075e-1	1.000000e+0	1.000000e+0	1.641285e+0	1.218558e+0	2	10992	1.000000e+0	1.819505e-4	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0043226	organelle	18	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	16	3.733721e-1	1.000000e+0	1.000000e+0	1.636520e+0	1.222105e+0	2	11024	1.000000e+0	1.814224e-4	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0044424	intracellular part	19	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	17	4.860618e-1	1.000000e+0	1.000000e+0	1.434330e+0	1.394379e+0	2	12578	1.000000e+0	1.590078e-4	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0005622	intracellular	20	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	19	4.992900e-1	1.000000e+0	1.000000e+0	1.415202e+0	1.413225e+0	2	12748	1.000000e+0	1.568874e-4	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0044464	cell part	21	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	21	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	CYP4F22,CYP4F3
GO Cellular Component	GO:0005623	cell	22	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	22	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	CYP4F22,CYP4F3
Human Phenotype	HP:0100758	Gangrene	1	5.616515e-4	1.000000e+0	1.000000e+0	1.780464e+3	5.616515e-4	1	5.616515e-4	1.000000e+0	3	1.219107e-3	1.000000e+0	1.000000e+0	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	CYP4F22
Human Phenotype	HP:0001036	Parakeratosis	2	5.994850e-4	1.000000e+0	1.000000e+0	1.668098e+3	5.994850e-4	1	5.994850e-4	1.000000e+0	1	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	CYP4F22
Human Phenotype	HP:0007479	Congenital nonbullous ichthyosiform erythroderma	3	6.856919e-4	1.000000e+0	1.000000e+0	1.458381e+3	6.856919e-4	1	6.856919e-4	1.000000e+0	3	1.219107e-3	1.000000e+0	1.000000e+0	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	CYP4F22
Human Phenotype	HP:0001927	Acanthocytosis	4	8.283819e-4	1.000000e+0	1.000000e+0	1.207173e+3	8.283819e-4	1	8.283819e-4	1.000000e+0	1	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	CYP4F22
Human Phenotype	HP:0001019	Erythroderma	5	9.143099e-4	1.000000e+0	1.000000e+0	1.093721e+3	9.143099e-4	1	9.143099e-4	1.000000e+0	5	1.773000e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	CYP4F22
Human Phenotype	HP:0007431	Congenital ichthyosiform erythroderma	6	1.360550e-3	1.000000e+0	1.000000e+0	7.349966e+2	1.360550e-3	1	1.360550e-3	1.000000e+0	6	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	CYP4F22
Human Phenotype	HP:0004447	Poikilocytosis	7	1.747994e-3	1.000000e+0	1.000000e+0	5.720843e+2	1.747994e-3	1	1.747994e-3	1.000000e+0	6	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	CYP4F22
Human Phenotype	HP:0100806	Sepsis	8	2.820733e-3	1.000000e+0	1.000000e+0	3.545178e+2	2.820733e-3	1	2.820733e-3	1.000000e+0	8	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	CYP4F22
Human Phenotype	HP:0100679	Lack of skin elasticity	9	3.316696e-3	1.000000e+0	1.000000e+0	3.015049e+2	3.316696e-3	1	3.316696e-3	1.000000e+0	8	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	CYP4F22
Human Phenotype	HP:0000989	Pruritus	10	4.613397e-3	1.000000e+0	1.000000e+0	2.167600e+2	4.613397e-3	1	4.613397e-3	1.000000e+0	11	6.419641e-3	1.000000e+0	1.000000e+0	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	CYP4F22
Human Phenotype	HP:0001944	Dehydration	11	4.742302e-3	1.000000e+0	1.000000e+0	2.108681e+2	4.742302e-3	1	4.742302e-3	1.000000e+0	10	5.203711e-3	1.000000e+0	1.000000e+0	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	CYP4F22
Human Phenotype	HP:0000958	Dry skin	12	6.613760e-3	1.000000e+0	1.000000e+0	1.511999e+2	6.613760e-3	1	6.613760e-3	1.000000e+0	16	9.621709e-3	1.000000e+0	1.000000e+0	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	CYP4F22
Human Phenotype	HP:0000388	Otitis media	13	7.575208e-3	1.000000e+0	1.000000e+0	1.320096e+2	7.575208e-3	1	7.575208e-3	1.000000e+0	17	1.083493e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	CYP4F22
Human Phenotype	HP:0000232	Everted lower lip vermilion	14	8.514182e-3	1.000000e+0	1.000000e+0	1.174511e+2	8.514182e-3	1	8.514182e-3	1.000000e+0	11	6.419641e-3	1.000000e+0	1.000000e+0	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	CYP4F22
Human Phenotype	HP:0012472	Eclabion	15	8.597810e-3	1.000000e+0	1.000000e+0	1.163087e+2	8.597810e-3	1	8.597810e-3	1.000000e+0	13	6.530143e-3	1.000000e+0	1.000000e+0	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	CYP4F22
Human Phenotype	HP:0008064	Ichthyosis	16	8.710125e-3	1.000000e+0	1.000000e+0	1.148089e+2	8.710125e-3	1	8.710125e-3	1.000000e+0	18	1.094519e-2	1.000000e+0	1.000000e+0	9.111616e+1	1.097500e-2	1	99	5.000000e-1	1.010101e-2	unnamed	CYP4F22
Human Phenotype	HP:0000982	Palmoplantar keratoderma	17	9.265830e-3	1.000000e+0	1.000000e+0	1.079234e+2	9.265830e-3	1	9.265830e-3	1.000000e+0	20	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	CYP4F22
Human Phenotype	HP:0011039	Abnormality of the helix	18	9.266737e-3	1.000000e+0	1.000000e+0	1.079128e+2	9.266737e-3	1	9.266737e-3	1.000000e+0	14	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	CYP4F22
Human Phenotype	HP:0100840	Aplasia/Hypoplasia of the eyebrow	19	9.416753e-3	1.000000e+0	1.000000e+0	1.061937e+2	9.416753e-3	1	9.416753e-3	1.000000e+0	15	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	CYP4F22
Human Phenotype	HP:0010647	Abnormal elasticity of skin	20	1.022197e-2	1.000000e+0	1.000000e+0	9.782851e+1	1.022197e-2	1	1.022197e-2	1.000000e+0	18	1.094519e-2	1.000000e+0	1.000000e+0	9.111616e+1	1.097500e-2	1	99	5.000000e-1	1.010101e-2	unnamed	CYP4F22
Human Phenotype	HP:0011123	Inflammatory abnormality of the skin	21	1.320793e-2	1.000000e+0	1.000000e+0	7.571211e+1	1.320793e-2	1	1.320793e-2	1.000000e+0	22	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	CYP4F22
Human Phenotype	HP:0000962	Hyperkeratosis	22	1.427604e-2	1.000000e+0	1.000000e+0	7.004741e+1	1.427604e-2	1	1.427604e-2	1.000000e+0	24	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	CYP4F22
Human Phenotype	HP:0011122	Abnormality of skin physiology	23	1.599685e-2	1.000000e+0	1.000000e+0	6.251231e+1	1.599685e-2	1	1.599685e-2	1.000000e+0	25	2.248791e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	CYP4F22
Human Phenotype	HP:0000083	Renal insufficiency	24	1.606537e-2	1.000000e+0	1.000000e+0	6.224567e+1	1.606537e-2	1	1.606537e-2	1.000000e+0	22	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	CYP4F22
Human Phenotype	HP:0000178	Abnormality of lower lip	25	1.671588e-2	1.000000e+0	1.000000e+0	5.982335e+1	1.671588e-2	1	1.671588e-2	1.000000e+0	21	1.425002e-2	1.000000e+0	1.000000e+0	6.992636e+1	1.430076e-2	1	129	5.000000e-1	7.751938e-3	unnamed	CYP4F22
Human Phenotype	HP:0002205	Recurrent respiratory infections	26	1.903666e-2	1.000000e+0	1.000000e+0	5.253023e+1	1.903666e-2	1	1.903666e-2	1.000000e+0	27	2.489780e-2	1.000000e+0	1.000000e+0	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	CYP4F22
Human Phenotype	HP:0011947	Respiratory tract infection	27	2.044241e-2	1.000000e+0	1.000000e+0	4.891792e+1	2.044241e-2	1	2.044241e-2	1.000000e+0	30	2.632043e-2	1.000000e+0	1.000000e+0	3.774268e+1	2.649521e-2	1	239	5.000000e-1	4.184100e-3	unnamed	CYP4F22
Human Phenotype	HP:0011368	Epidermal thickening	28	2.108661e-2	1.000000e+0	1.000000e+0	4.742345e+1	2.108661e-2	1	2.108661e-2	1.000000e+0	32	2.796063e-2	1.000000e+0	1.000000e+0	3.551378e+1	2.815808e-2	1	254	5.000000e-1	3.937008e-3	unnamed	CYP4F22
Human Phenotype	HP:0001877	Abnormality of erythrocytes	29	2.240890e-2	1.000000e+0	1.000000e+0	4.462513e+1	2.240890e-2	1	2.240890e-2	1.000000e+0	35	3.101865e-2	1.000000e+0	1.000000e+0	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	CYP4F22
Human Phenotype	HP:0000370	Abnormality of the middle ear	30	2.356312e-2	1.000000e+0	1.000000e+0	4.243920e+1	2.356312e-2	1	2.356312e-2	1.000000e+0	28	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	CYP4F22
Human Phenotype	HP:0001072	Thickened skin	31	2.357460e-2	1.000000e+0	1.000000e+0	4.241854e+1	2.357460e-2	1	2.357460e-2	1.000000e+0	34	3.036376e-2	1.000000e+0	1.000000e+0	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	CYP4F22
Human Phenotype	HP:0011032	Abnormality of fluid regulation	32	2.390611e-2	1.000000e+0	1.000000e+0	4.183031e+1	2.390611e-2	1	2.390611e-2	1.000000e+0	31	2.708603e-2	1.000000e+0	1.000000e+0	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	CYP4F22
Human Phenotype	HP:0001597	Abnormality of the nail	33	2.408581e-2	1.000000e+0	1.000000e+0	4.151823e+1	2.408581e-2	1	2.408581e-2	1.000000e+0	29	2.610163e-2	1.000000e+0	1.000000e+0	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	CYP4F22
Human Phenotype	HP:0000082	Abnormality of renal physiology	34	2.423866e-2	1.000000e+0	1.000000e+0	4.125641e+1	2.423866e-2	1	2.423866e-2	1.000000e+0	33	2.850706e-2	1.000000e+0	1.000000e+0	3.482819e+1	2.871238e-2	1	259	5.000000e-1	3.861004e-3	unnamed	CYP4F22
Human Phenotype	HP:0000534	Abnormality of the eyebrow	35	2.637232e-2	1.000000e+0	1.000000e+0	3.791855e+1	2.637232e-2	1	2.637232e-2	1.000000e+0	26	2.424086e-2	1.000000e+0	1.000000e+0	4.100227e+1	2.438889e-2	1	220	5.000000e-1	4.545455e-3	unnamed	CYP4F22
Human Phenotype	HP:0002719	Recurrent infections	36	2.831519e-2	1.000000e+0	1.000000e+0	3.531673e+1	2.831519e-2	1	2.831519e-2	1.000000e+0	39	3.624975e-2	1.000000e+0	1.000000e+0	2.733485e+1	3.658334e-2	1	330	5.000000e-1	3.030303e-3	unnamed	CYP4F22
Human Phenotype	HP:0000377	Abnormality of the pinna	37	3.568518e-2	1.000000e+0	1.000000e+0	2.802284e+1	3.568518e-2	1	3.568518e-2	1.000000e+0	36	3.112777e-2	1.000000e+0	1.000000e+0	3.187456e+1	3.137298e-2	1	283	5.000000e-1	3.533569e-3	unnamed	CYP4F22
Human Phenotype	HP:0011362	Abnormal hair quantity	38	3.605802e-2	1.000000e+0	1.000000e+0	2.773308e+1	3.605802e-2	1	3.605802e-2	1.000000e+0	38	3.505220e-2	1.000000e+0	1.000000e+0	2.827743e+1	3.536389e-2	1	319	5.000000e-1	3.134796e-3	unnamed	CYP4F22
Human Phenotype	HP:0011277	Abnormality of the urinary system physiology	39	3.851912e-2	1.000000e+0	1.000000e+0	2.596113e+1	3.851912e-2	1	3.851912e-2	1.000000e+0	41	4.623645e-2	1.000000e+0	1.000000e+0	2.137559e+1	4.678233e-2	1	422	5.000000e-1	2.369668e-3	unnamed	CYP4F22
Human Phenotype	HP:0010978	Abnormality of immune system physiology	40	4.120940e-2	1.000000e+0	1.000000e+0	2.426631e+1	4.120940e-2	1	4.120940e-2	1.000000e+0	44	5.336878e-2	1.000000e+0	1.000000e+0	1.848463e+1	5.409900e-2	1	488	5.000000e-1	2.049180e-3	unnamed	CYP4F22
Human Phenotype	HP:0000159	Abnormality of the lip	41	4.273885e-2	1.000000e+0	1.000000e+0	2.339791e+1	4.273885e-2	1	4.273885e-2	1.000000e+0	37	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	CYP4F22
Human Phenotype	HP:0000164	Abnormality of the teeth	42	5.299708e-2	1.000000e+0	1.000000e+0	1.886896e+1	5.299708e-2	1	5.299708e-2	1.000000e+0	40	4.591162e-2	1.000000e+0	1.000000e+0	2.152864e+1	4.644975e-2	1	419	5.000000e-1	2.386635e-3	unnamed	CYP4F22
Human Phenotype	HP:0011121	Abnormality of skin morphology	43	5.311577e-2	1.000000e+0	1.000000e+0	1.882680e+1	5.311577e-2	1	5.311577e-2	1.000000e+0	47	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	CYP4F22
Human Phenotype	HP:0001595	Abnormality of the hair	44	5.637295e-2	1.000000e+0	1.000000e+0	1.773901e+1	5.637295e-2	1	5.637295e-2	1.000000e+0	45	5.509380e-2	1.000000e+0	1.000000e+0	1.789782e+1	5.587273e-2	1	504	5.000000e-1	1.984127e-3	unnamed	CYP4F22
Human Phenotype	HP:0000492	Abnormality of the eyelid	45	5.671593e-2	1.000000e+0	1.000000e+0	1.763173e+1	5.671593e-2	1	5.671593e-2	1.000000e+0	42	4.969789e-2	1.000000e+0	1.000000e+0	1.986894e+1	5.032980e-2	1	454	5.000000e-1	2.202643e-3	unnamed	CYP4F22
Human Phenotype	HP:0000356	Abnormality of the outer ear	46	5.750419e-2	1.000000e+0	1.000000e+0	1.739004e+1	5.750419e-2	1	5.750419e-2	1.000000e+0	43	5.196604e-2	1.000000e+0	1.000000e+0	1.899053e+1	5.265783e-2	1	475	5.000000e-1	2.105263e-3	unnamed	CYP4F22
Human Phenotype	HP:0001871	Abnormality of  blood and blood-forming tissues	47	5.831227e-2	1.000000e+0	1.000000e+0	1.714905e+1	5.831227e-2	1	5.831227e-2	1.000000e+0	53	7.577790e-2	1.000000e+0	1.000000e+0	1.294189e+1	7.726844e-2	1	697	5.000000e-1	1.434720e-3	unnamed	CYP4F22
Human Phenotype	HP:0002088	Abnormality of the lung	48	5.867133e-2	1.000000e+0	1.000000e+0	1.704410e+1	5.867133e-2	1	5.867133e-2	1.000000e+0	51	6.990679e-2	1.000000e+0	1.000000e+0	1.405062e+1	7.117122e-2	1	642	5.000000e-1	1.557632e-3	unnamed	CYP4F22
Human Phenotype	HP:0004322	Short stature	49	6.307451e-2	1.000000e+0	1.000000e+0	1.585427e+1	6.307451e-2	1	6.307451e-2	1.000000e+0	48	6.197814e-2	1.000000e+0	1.000000e+0	1.588116e+1	6.296768e-2	1	568	5.000000e-1	1.760563e-3	unnamed	CYP4F22
Human Phenotype	HP:0000606	Abnormality of the periorbital region	50	6.436496e-2	1.000000e+0	1.000000e+0	1.553640e+1	6.436496e-2	1	6.436496e-2	1.000000e+0	46	5.724786e-2	1.000000e+0	1.000000e+0	1.721469e+1	5.808991e-2	1	524	5.000000e-1	1.908397e-3	unnamed	CYP4F22
Human Phenotype	HP:0000002	Abnormality of body height	51	6.858327e-2	1.000000e+0	1.000000e+0	1.458081e+1	6.858327e-2	1	6.858327e-2	1.000000e+0	49	6.637520e-2	1.000000e+0	1.000000e+0	1.481199e+1	6.751289e-2	1	609	5.000000e-1	1.642036e-3	unnamed	CYP4F22
Human Phenotype	HP:0011138	Abnormality of skin adnexa	52	6.863693e-2	1.000000e+0	1.000000e+0	1.456942e+1	6.863693e-2	1	6.863693e-2	1.000000e+0	50	6.798130e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	624	5.000000e-1	1.602564e-3	unnamed	CYP4F22
Human Phenotype	HP:0002715	Abnormality of the immune system	53	7.036261e-2	1.000000e+0	1.000000e+0	1.421209e+1	7.036261e-2	1	7.036261e-2	1.000000e+0	55	8.555712e-2	1.000000e+0	1.000000e+0	1.143283e+1	8.746744e-2	1	789	5.000000e-1	1.267427e-3	unnamed	CYP4F22
Human Phenotype	HP:0001510	Growth delay	54	7.829812e-2	1.000000e+0	1.000000e+0	1.277170e+1	7.829812e-2	1	7.829812e-2	1.000000e+0	54	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	CYP4F22
Human Phenotype	HP:0011354	Generalized abnormality of skin	55	7.852036e-2	1.000000e+0	1.000000e+0	1.273555e+1	7.852036e-2	1	7.852036e-2	1.000000e+0	59	9.349082e-2	1.000000e+0	1.000000e+0	1.044039e+1	9.578183e-2	1	864	5.000000e-1	1.157407e-3	unnamed	CYP4F22
Human Phenotype	HP:0012252	Abnormal respiratory system morphology	56	8.040224e-2	1.000000e+0	1.000000e+0	1.243746e+1	8.040224e-2	1	8.040224e-2	1.000000e+0	57	8.661694e-2	1.000000e+0	1.000000e+0	1.128974e+1	8.857602e-2	1	799	5.000000e-1	1.251564e-3	unnamed	CYP4F22
Human Phenotype	HP:0000284	Abnormality of the ocular region	57	8.041999e-2	1.000000e+0	1.000000e+0	1.243472e+1	8.041999e-2	1	8.041999e-2	1.000000e+0	52	7.204389e-2	1.000000e+0	1.000000e+0	1.362613e+1	7.338839e-2	1	662	5.000000e-1	1.510574e-3	unnamed	CYP4F22
Human Phenotype	HP:0002086	Abnormality of the respiratory system	58	8.717457e-2	1.000000e+0	1.000000e+0	1.147124e+1	8.717457e-2	1	8.717457e-2	1.000000e+0	60	9.359637e-2	1.000000e+0	1.000000e+0	1.042832e+1	9.589269e-2	1	865	5.000000e-1	1.156069e-3	unnamed	CYP4F22
Human Phenotype	HP:0000079	Abnormality of the urinary system	59	8.807497e-2	1.000000e+0	1.000000e+0	1.135396e+1	8.807497e-2	1	8.807497e-2	1.000000e+0	58	9.053295e-2	1.000000e+0	1.000000e+0	1.079007e+1	9.267779e-2	1	836	5.000000e-1	1.196172e-3	unnamed	CYP4F22
Human Phenotype	HP:0000163	Abnormality of the oral cavity	60	8.862539e-2	1.000000e+0	1.000000e+0	1.128345e+1	8.862539e-2	1	8.862539e-2	1.000000e+0	56	8.576913e-2	1.000000e+0	1.000000e+0	1.140392e+1	8.768915e-2	1	791	5.000000e-1	1.264223e-3	unnamed	CYP4F22
Human Phenotype	HP:0000951	Abnormality of the skin	61	9.900756e-2	1.000000e+0	1.000000e+0	1.010024e+1	9.900756e-2	1	9.900756e-2	1.000000e+0	63	1.100914e-1	1.000000e+0	1.000000e+0	8.826321e+0	1.132975e-1	1	1022	5.000000e-1	9.784736e-4	unnamed	CYP4F22
Human Phenotype	HP:0000153	Abnormality of the mouth	62	1.037371e-1	1.000000e+0	1.000000e+0	9.639755e+0	1.037371e-1	1	1.037371e-1	1.000000e+0	61	9.823445e-2	1.000000e+0	1.000000e+0	9.923542e+0	1.007705e-1	1	909	5.000000e-1	1.100110e-3	unnamed	CYP4F22
Human Phenotype	HP:0000598	Abnormality of the ear	63	1.055161e-1	1.000000e+0	1.000000e+0	9.477228e+0	1.055161e-1	1	1.055161e-1	1.000000e+0	62	1.062177e-1	1.000000e+0	1.000000e+0	9.157868e+0	1.091957e-1	1	985	5.000000e-1	1.015228e-3	unnamed	CYP4F22
Human Phenotype	HP:0001507	Growth abnormality	64	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	64	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	CYP4F22
Human Phenotype	HP:0000119	Abnormality of the genitourinary system	65	1.156102e-1	1.000000e+0	1.000000e+0	8.649757e+0	1.156102e-1	1	1.156102e-1	1.000000e+0	65	1.209346e-1	1.000000e+0	1.000000e+0	8.011101e+0	1.248268e-1	1	1126	5.000000e-1	8.880995e-4	unnamed	CYP4F22
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	66	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	69	1.414974e-1	1.000000e+0	1.000000e+0	6.807925e+0	1.468876e-1	1	1325	5.000000e-1	7.547170e-4	unnamed	CYP4F22
Human Phenotype	HP:0001574	Abnormality of the integument	67	1.221743e-1	1.000000e+0	1.000000e+0	8.185030e+0	1.221743e-1	1	1.221743e-1	1.000000e+0	66	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	CYP4F22
Human Phenotype	HP:0100543	Cognitive impairment	68	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	67	1.328473e-1	1.000000e+0	1.000000e+0	7.268735e+0	1.375755e-1	1	1241	5.000000e-1	8.058018e-4	unnamed	CYP4F22
Human Phenotype	HP:0000271	Abnormality of the face	69	1.330333e-1	1.000000e+0	1.000000e+0	7.516916e+0	1.330333e-1	1	1.330333e-1	1.000000e+0	68	1.358386e-1	1.000000e+0	1.000000e+0	7.102756e+0	1.407904e-1	1	1270	5.000000e-1	7.874016e-4	unnamed	CYP4F22
Human Phenotype	HP:0000007	Autosomal recessive inheritance	70	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	73	1.705229e-1	1.000000e+0	1.000000e+0	5.602795e+0	1.784823e-1	1	1610	5.000000e-1	6.211180e-4	unnamed	CYP4F22
Human Phenotype	HP:0011446	Abnormality of higher mental function	71	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	70	1.507173e-1	1.000000e+0	1.000000e+0	6.374912e+0	1.568649e-1	1	1415	5.000000e-1	7.067138e-4	unnamed	CYP4F22
Human Phenotype	HP:0000234	Abnormality of the head	72	1.454011e-1	1.000000e+0	1.000000e+0	6.877527e+0	1.454011e-1	1	1.454011e-1	1.000000e+0	71	1.516365e-1	1.000000e+0	1.000000e+0	6.334621e+0	1.578626e-1	1	1424	5.000000e-1	7.022472e-4	unnamed	CYP4F22
Human Phenotype	HP:0000152	Abnormality of head and neck	73	1.484435e-1	1.000000e+0	1.000000e+0	6.736568e+0	1.484435e-1	1	1.484435e-1	1.000000e+0	72	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	CYP4F22
Human Phenotype	HP:0002011	Abnormality of the central nervous system	74	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	74	1.821938e-1	1.000000e+0	1.000000e+0	5.226246e+0	1.913419e-1	1	1726	5.000000e-1	5.793743e-4	unnamed	CYP4F22
Human Phenotype	HP:0000707	Abnormality of the nervous system	75	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	75	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	CYP4F22
Human Phenotype	HP:0000005	Mode of inheritance	76	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	76	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	CYP4F22
Human Phenotype	HP:0000118	Phenotypic abnormality	77	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	77	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	CYP4F22
Human Phenotype	HP:0000001	All	78	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	78	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	CYP4F22
Disease Ontology	DOID:1699	congenital ichthyosiform erythroderma	1	3.642984e-4	8.142069e-1	8.142069e-1	2.745002e+3	3.642984e-4	1	3.642984e-4	1.000000e+0	1	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	CYP4F22
Disease Ontology	DOID:0050177	simple genetic disease	2	5.697693e-2	1.000000e+0	1.000000e+0	1.755096e+1	5.697693e-2	1	5.697693e-2	1.000000e+0	2	6.337345e-2	1.000000e+0	1.000000e+0	1.552582e+1	6.440885e-2	1	581	5.000000e-1	1.721170e-3	unnamed	CYP4F22
Disease Ontology	DOID:630	genetic disease	3	6.499915e-2	1.000000e+0	1.000000e+0	1.538482e+1	6.499915e-2	1	6.499915e-2	1.000000e+0	3	6.926518e-2	1.000000e+0	1.000000e+0	1.418318e+1	7.050607e-2	1	636	5.000000e-1	1.572327e-3	unnamed	CYP4F22
Disease Ontology	DOID:2985	chronic rejection of renal transplant	4	2.674662e-1	1.000000e+0	1.000000e+0	3.738791e+0	2.674662e-1	1	2.674662e-1	1.000000e+0	5	2.866046e-1	1.000000e+0	1.000000e+0	3.218159e+0	3.107367e-1	1	2803	5.000000e-1	3.567606e-4	unnamed	CYP4F3
Disease Ontology	DOID:2108	transplant-related disease	5	2.674780e-1	1.000000e+0	1.000000e+0	3.738626e+0	2.674780e-1	1	2.674780e-1	1.000000e+0	6	2.866982e-1	1.000000e+0	1.000000e+0	3.217011e+0	3.108475e-1	1	2804	5.000000e-1	3.566334e-4	unnamed	CYP4F3
Disease Ontology	DOID:557	kidney disease	6	2.854845e-1	1.000000e+0	1.000000e+0	3.502817e+0	2.854845e-1	1	2.854845e-1	1.000000e+0	7	3.062252e-1	1.000000e+0	1.000000e+0	2.992867e+0	3.341278e-1	1	3014	5.000000e-1	3.317850e-4	unnamed	CYP4F3
Disease Ontology	DOID:18	urinary system disease	7	2.923209e-1	1.000000e+0	1.000000e+0	3.420898e+0	2.923209e-1	1	2.923209e-1	1.000000e+0	8	3.122143e-1	1.000000e+0	1.000000e+0	2.929685e+0	3.413336e-1	1	3079	5.000000e-1	3.247808e-4	unnamed	CYP4F3
Disease Ontology	DOID:2914	immune system disease	8	3.205063e-1	1.000000e+0	1.000000e+0	3.120063e+0	3.205063e-1	1	3.205063e-1	1.000000e+0	9	3.434783e-1	1.000000e+0	1.000000e+0	2.635261e+0	3.794690e-1	1	3423	5.000000e-1	2.921414e-4	unnamed	CYP4F3
Disease Ontology	DOID:7	disease of anatomical entity	9	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	10	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	CYP4F3
Disease Ontology	DOID:4	disease	10	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	4	1.910563e-1	1.000000e+0	1.000000e+0	2.287725e+0	8.742309e-1	2	7886	1.000000e+0	2.536140e-4	unnamed	CYP4F22,CYP4F3
MSigDB Pathway	KEGG_ARACHIDONIC_ACID_METABOLISM	Arachidonic acid metabolism	1	2.841231e-3	1.000000e+0	1.000000e+0	3.519601e+2	2.841231e-3	1	2.841231e-3	1.000000e+0	2	6.309133e-3	1.000000e+0	1.000000e+0	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	CYP4F3
MSigDB Pathway	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	Genes involved in Cytochrome P450 - arranged by substrate type	2	3.299688e-3	1.000000e+0	1.000000e+0	3.030590e+2	3.299688e-3	1	3.299688e-3	1.000000e+0	1	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	CYP4F3
MSigDB Pathway	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS	Genes involved in Phase 1 - Functionalization of compounds	3	4.733687e-3	1.000000e+0	1.000000e+0	2.112518e+2	4.733687e-3	1	4.733687e-3	1.000000e+0	3	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	CYP4F3
MSigDB Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	Genes involved in Biological oxidations	4	8.699493e-3	1.000000e+0	1.000000e+0	1.149492e+2	8.699493e-3	1	8.699493e-3	1.000000e+0	4	1.502036e-2	1.000000e+0	1.000000e+0	6.632721e+1	1.507677e-2	1	136	5.000000e-1	7.352941e-3	unnamed	CYP4F3
MSigDB Perturbation	SUMI_HNF4A_TARGETS	Genes up-regulated in HepG2 cells (hepatocellular carcinoma, HCC) upon expression of HNF4A [GeneID=3172] and down-regulated upon knockdown of HNF4A [GeneID=3172] in these cells by RNAi.	1	2.169128e-3	1.000000e+0	1.000000e+0	4.610146e+2	2.169128e-3	1	2.169128e-3	1.000000e+0	1	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	CYP4F3
MSigDB Perturbation	HECKER_IFNB1_TARGETS	Genes transcriptionally modulated in the blood of multiple sclerosis patients in response to subcutaneous treatment with recombinant IFNB1 [GeneID = 3456].	2	5.256113e-3	1.000000e+0	1.000000e+0	1.902546e+2	5.256113e-3	1	5.256113e-3	1.000000e+0	4	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	CYP4F3
MSigDB Perturbation	WOO_LIVER_CANCER_RECURRENCE_DN	Genes negatively correlated with recurrence free survival in patients with hepatitis B-related (HBV) hepatocellular carcinoma (HCC).	3	5.961475e-3	1.000000e+0	1.000000e+0	1.677437e+2	5.961475e-3	1	5.961475e-3	1.000000e+0	3	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	CYP4F3
MSigDB Perturbation	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	Genes with high-CpG-density promoters (HCP) without H3 methylation marks at either H3K4 or H3K27 in MCV8.1 cells (induced pluripotent cells, iPS).	4	7.666352e-3	1.000000e+0	1.000000e+0	1.304401e+2	7.666352e-3	1	7.666352e-3	1.000000e+0	2	8.407740e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	CYP4F22
MSigDB Perturbation	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	Genes down-regulated by flavopiridol [PubChem=5287969] in the HCT116 cells (colon cancer) depending on their TP53 [GeneID=7157] status: wild-type vs loss of the gene's function (LOF).	5	8.852750e-3	1.000000e+0	1.000000e+0	1.129592e+2	8.852750e-3	1	8.852750e-3	1.000000e+0	5	1.149638e-2	1.000000e+0	1.000000e+0	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	CYP4F3
MSigDB Perturbation	ONDER_CDH1_TARGETS_1_UP	Genes up-regulated in HMLE cells (mmortalized nontransformed mammary epithelial) by expression of a dominant-negative form of E-cadhedrin (CDH1) [GeneID=999].	6	1.107453e-2	1.000000e+0	1.000000e+0	9.029732e+1	1.107453e-2	1	1.107453e-2	1.000000e+0	8	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	CYP4F3
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	Genes down-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 16 days after transduction.	7	1.371444e-2	1.000000e+0	1.000000e+0	7.291586e+1	1.371444e-2	1	1.371444e-2	1.000000e+0	7	1.369960e-2	1.000000e+0	1.000000e+0	7.274597e+1	1.374647e-2	1	124	5.000000e-1	8.064516e-3	unnamed	CYP4F3
MSigDB Perturbation	XU_GH1_EXOGENOUS_TARGETS_DN	Genes down-regulated in MFCF-7 cells (breast cancer) by exogenous HG1 [GeneID=2688].	8	1.410285e-2	1.000000e+0	1.000000e+0	7.090764e+1	1.410285e-2	1	1.410285e-2	1.000000e+0	6	1.270846e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	CYP4F3
MSigDB Perturbation	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	Top 200 marker genes down-regulated in the 'proliferation' subclass of hepatocellular carcinoma (HCC); characterized by increased proliferation, high levels of serum AFP [GeneID=174], and chromosomal instability.	9	1.416646e-2	1.000000e+0	1.000000e+0	7.058926e+1	1.416646e-2	1	1.416646e-2	1.000000e+0	11	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	CYP4F3
MSigDB Perturbation	SMIRNOV_RESPONSE_TO_IR_6HR_UP	Genes up-regulated in B lymphocytes at 6 h after exprosure to 10 Gy dose of ionizing radiation.	10	1.433802e-2	1.000000e+0	1.000000e+0	6.974465e+1	1.433802e-2	1	1.433802e-2	1.000000e+0	9	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	CYP4F3
MSigDB Perturbation	WANG_CISPLATIN_RESPONSE_AND_XPC_UP	Genes up-regulated in fibroblasts with defective XPC [GeneID=7508] in response to cisplatin [PubChem=2767].	11	1.771781e-2	1.000000e+0	1.000000e+0	5.644040e+1	1.771781e-2	1	1.771781e-2	1.000000e+0	12	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	CYP4F3
MSigDB Perturbation	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	Genes bound by ESR1 [GeneID=2099] and up-regulated by estradiol [PubChemID=5757] in MCF-7 cells (breast cancer).	12	1.846262e-2	1.000000e+0	1.000000e+0	5.416350e+1	1.846262e-2	1	1.846262e-2	1.000000e+0	13	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	CYP4F22
MSigDB Perturbation	CHYLA_CBFA2T3_TARGETS_DN	Genes down-regulated in immature bone marrow progenitor cells upon knock out of CBFA2T3 [GeneID=863].	13	2.110180e-2	1.000000e+0	1.000000e+0	4.738933e+1	2.110180e-2	1	2.110180e-2	1.000000e+0	15	2.456936e-2	1.000000e+0	1.000000e+0	4.045067e+1	2.472147e-2	1	223	5.000000e-1	4.484305e-3	unnamed	CYP4F22
MSigDB Perturbation	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	Top 200 marker genes down-regulated in the 'CTNNB1' subclass of hepatocellular carcinoma (HCC); characterized by activated CTNNB1 [GeneID=1499].	14	2.177156e-2	1.000000e+0	1.000000e+0	4.593149e+1	2.177156e-2	1	2.177156e-2	1.000000e+0	9	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	CYP4F22
MSigDB Perturbation	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	Genes down-regulated in CD133+ [GeneID=8842] cells (hematopoietic stem cells, HSC) compared to the CD133- cells.	15	2.231905e-2	1.000000e+0	1.000000e+0	4.480478e+1	2.231905e-2	1	2.231905e-2	1.000000e+0	14	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	CYP4F3
MSigDB Perturbation	MEISSNER_BRAIN_HCP_WITH_H3K27ME3	Genes with high-CpG-density promoters (HCP) bearing the H3K27 tri-methylation (H3K27me3) mark in brain.	16	2.329266e-2	1.000000e+0	1.000000e+0	4.293199e+1	2.329266e-2	1	2.329266e-2	1.000000e+0	16	2.883484e-2	1.000000e+0	1.000000e+0	3.442939e+1	2.904495e-2	1	262	5.000000e-1	3.816794e-3	unnamed	CYP4F22
MSigDB Perturbation	BHAT_ESR1_TARGETS_VIA_AKT1_UP	Genes bound by ESR1 [GeneID=2099] and up-regulated by estradiol [PubChemID=5757] in MCF-7 cells (breast cancer) expressing constitutevly active form of AKT1 [GeneID=207].	17	2.344270e-2	1.000000e+0	1.000000e+0	4.265720e+1	2.344270e-2	1	2.344270e-2	1.000000e+0	17	3.003624e-2	1.000000e+0	1.000000e+0	3.304212e+1	3.026440e-2	1	273	5.000000e-1	3.663004e-3	unnamed	CYP4F22
MSigDB Perturbation	SANSOM_APC_TARGETS_DN	Top genes down-regulated at day 5 of Cre-Lox induced APC [GeneID=324] knockout in the intestine.	18	2.681360e-2	1.000000e+0	1.000000e+0	3.729450e+1	2.681360e-2	1	2.681360e-2	1.000000e+0	18	3.972928e-2	1.000000e+0	1.000000e+0	2.491851e+1	4.013081e-2	1	362	5.000000e-1	2.762431e-3	unnamed	CYP4F3
MSigDB Perturbation	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	Genes up-regulated in patients at the incipient stage of Alzheimer's disease.	19	3.763783e-2	1.000000e+0	1.000000e+0	2.656901e+1	3.763783e-2	1	3.763783e-2	1.000000e+0	19	4.255177e-2	1.000000e+0	1.000000e+0	2.324871e+1	4.301314e-2	1	388	5.000000e-1	2.577320e-3	unnamed	CYP4F3
MSigDB Perturbation	ACEVEDO_LIVER_CANCER_DN	Genes down-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	20	4.027354e-2	1.000000e+0	1.000000e+0	2.483020e+1	4.027354e-2	1	4.027354e-2	1.000000e+0	22	5.810880e-2	1.000000e+0	1.000000e+0	1.695583e+1	5.897678e-2	1	532	5.000000e-1	1.879699e-3	unnamed	CYP4F22
MSigDB Perturbation	MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED	Genes with high-CpG-density promoters (HCP) that have no histone H3 methylation marks in neural precursor cells (NPC).	21	4.950690e-2	1.000000e+0	1.000000e+0	2.019921e+1	4.950690e-2	1	4.950690e-2	1.000000e+0	21	5.520156e-2	1.000000e+0	1.000000e+0	1.786238e+1	5.598359e-2	1	505	5.000000e-1	1.980198e-3	unnamed	CYP4F22
MSigDB Perturbation	RIGGI_EWING_SARCOMA_PROGENITOR_UP	Genes up-regulated in mesenchymal stem cells (MSC) engineered to express EWS-FLI1 [GeneID=2130;2321] fusion protein.	22	7.155100e-2	1.000000e+0	1.000000e+0	1.397605e+1	7.155100e-2	1	7.155100e-2	1.000000e+0	20	4.656123e-2	1.000000e+0	1.000000e+0	2.122471e+1	4.711490e-2	1	425	5.000000e-1	2.352941e-3	unnamed	CYP4F22
MSigDB Perturbation	MIKKELSEN_MEF_HCP_WITH_H3K27ME3	Genes with high-CpG-density promoters (HCP) bearing histone H3 trimethylation mark at K27 (H3K27me3) in MEF cells (embryonic fibroblast).	23	7.673530e-2	1.000000e+0	1.000000e+0	1.303181e+1	7.673530e-2	1	7.673530e-2	1.000000e+0	23	6.251492e-2	1.000000e+0	1.000000e+0	1.574258e+1	6.352198e-2	1	573	5.000000e-1	1.745201e-3	unnamed	CYP4F22
MSigDB Perturbation	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A	Category A genes: p53-dependent genes whose expression in the absence of S389 phosphorylation is similar to loss of TP53 [GeneID=7157] in MEF (embryonic fibroblast) cells in response to UV-C irradiation.	24	9.103755e-2	1.000000e+0	1.000000e+0	1.098448e+1	9.103755e-2	1	9.103755e-2	1.000000e+0	24	9.211812e-2	1.000000e+0	1.000000e+0	1.059988e+1	9.434067e-2	1	851	5.000000e-1	1.175088e-3	unnamed	CYP4F3
MSigDB Perturbation	PEREZ_TP53_TARGETS	Genes up-regulated in the HMEC cells (primary mammary epithelium) upon expression of TP53 [GeneID=7157] off adenoviral vector.	25	1.077316e-1	1.000000e+0	1.000000e+0	9.282326e+0	1.077316e-1	1	1.077316e-1	1.000000e+0	25	1.145827e-1	1.000000e+0	1.000000e+0	8.469953e+0	1.180644e-1	1	1065	5.000000e-1	9.389671e-4	unnamed	CYP4F3
MSigDB Perturbation	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	Genes up-regulated in TC71 and EWS502 cells (Ewing's sarcoma) by EWSR1-FLI1  [GeneID=2130;2314] as inferred from RNAi knockdown of this fusion protein.	26	1.219335e-1	1.000000e+0	1.000000e+0	8.201193e+0	1.219335e-1	1	1.219335e-1	1.000000e+0	26	1.314014e-1	1.000000e+0	1.000000e+0	7.351671e+0	1.360235e-1	1	1227	5.000000e-1	8.149959e-4	unnamed	CYP4F22
MSigDB Perturbation	BLALOCK_ALZHEIMERS_DISEASE_UP	Genes up-regulated in brain from patients with Alzheimer's disease.	27	1.561268e-1	1.000000e+0	1.000000e+0	6.405052e+0	1.561268e-1	1	1.561268e-1	1.000000e+0	28	1.768717e-1	1.000000e+0	1.000000e+0	5.391811e+0	1.854664e-1	1	1673	5.000000e-1	5.977286e-4	unnamed	CYP4F3
MSigDB Perturbation	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY	Genes transiently induced only by the first pulse of EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	28	1.656740e-1	1.000000e+0	1.000000e+0	6.035952e+0	1.656740e-1	1	1.656740e-1	1.000000e+0	27	1.708257e-1	1.000000e+0	1.000000e+0	5.592374e+0	1.788149e-1	1	1613	5.000000e-1	6.199628e-4	unnamed	CYP4F3
MSigDB miRNA Motifs	GCTGAGT,MIR-512-5P	Targets of MicroRNA GCTGAGT,MIR-512-5P	1	7.146102e-3	1.000000e+0	1.000000e+0	1.399364e+2	7.146102e-3	1	7.146102e-3	1.000000e+0	1	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	CYP4F22
InterPro	IPR002401	Cytochrome P450, E-class, group I	1	2.105465e-3	1.000000e+0	1.000000e+0	4.749545e+2	2.105465e-3	1	2.105465e-3	1.000000e+0	1	6.083704e-6	5.732066e-2	5.732066e-2	4.009111e+2	4.988637e-3	2	45	1.000000e+0	4.444444e-2	unnamed	CYP4F22,CYP4F3
InterPro	IPR017972	Cytochrome P450, conserved site	2	2.824642e-3	1.000000e+0	1.000000e+0	3.540271e+2	2.824642e-3	1	2.824642e-3	1.000000e+0	2	7.835073e-6	7.382206e-2	3.691103e-2	3.537451e+2	5.653789e-3	2	51	1.000000e+0	3.921569e-2	unnamed	CYP4F22,CYP4F3
InterPro	IPR001128	Cytochrome P450	3	3.500906e-3	1.000000e+0	1.000000e+0	2.856403e+2	3.500906e-3	1	3.500906e-3	1.000000e+0	3	9.463539e-6	8.916546e-2	2.972182e-2	3.221607e+2	6.208082e-3	2	56	1.000000e+0	3.571429e-2	unnamed	CYP4F22,CYP4F3
HGNC Gene Families	CYP	CYP	1	3.500906e-3	1.000000e+0	1.000000e+0	2.856403e+2	3.500906e-3	1	3.500906e-3	1.000000e+0	1	9.463539e-6	4.523572e-3	4.523572e-3	3.221607e+2	6.208082e-3	2	56	1.000000e+0	3.571429e-2	unnamed	CYP4F22,CYP4F3
Ensembl Genes	9662	CYP4F22	1	5.278803e-5	9.523488e-1	9.523488e-1	1.894369e+4	5.278803e-5	1	5.278803e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	CYP4F22
Ensembl Genes	9663	CYP4F3	2	5.531062e-5	9.978589e-1	4.989294e-1	1.807971e+4	5.531062e-5	1	5.531062e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	CYP4F3
MSigDB Oncogenic Signatures	CTIP_DN.V1_DN	Genes down-regulated in MCF10A cells (breast cancer) upon knockdown of RBBP8 [Gene ID=RBBP8] gene by RNAi.	1	1.115175e-2	1.000000e+0	1.000000e+0	8.967202e+1	1.115175e-2	1	1.115175e-2	1.000000e+0	1	1.369960e-2	1.000000e+0	1.000000e+0	7.274597e+1	1.374647e-2	1	124	5.000000e-1	8.064516e-3	unnamed	CYP4F3
MSigDB Oncogenic Signatures	ATM_DN.V1_UP	Genes up-regulated in HEK293 cells (kidney fibroblasts) upon knockdown of ATM [Gene ID=472] gene by RNAi.	2	1.203740e-2	1.000000e+0	1.000000e+0	8.307440e+1	1.203740e-2	1	1.203740e-2	1.000000e+0	2	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	CYP4F3
MSigDB Oncogenic Signatures	STK33_NOMO_DN	Genes down-regulated in NOMO-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	3	2.785871e-2	1.000000e+0	1.000000e+0	3.589541e+1	2.785871e-2	1	2.785871e-2	1.000000e+0	5	2.828851e-2	1.000000e+0	1.000000e+0	3.509922e+1	2.849066e-2	1	257	5.000000e-1	3.891051e-3	unnamed	CYP4F3
MSigDB Oncogenic Signatures	STK33_DN	Genes down-regulated in NOMO-1 and SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	4	2.905807e-2	1.000000e+0	1.000000e+0	3.441385e+1	2.905807e-2	1	2.905807e-2	1.000000e+0	3	2.796063e-2	1.000000e+0	1.000000e+0	3.551378e+1	2.815808e-2	1	254	5.000000e-1	3.937008e-3	unnamed	CYP4F3
MSigDB Oncogenic Signatures	STK33_SKM_DN	Genes down-regulated in SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	5	3.216178e-2	1.000000e+0	1.000000e+0	3.109281e+1	3.216178e-2	1	3.216178e-2	1.000000e+0	3	2.796063e-2	1.000000e+0	1.000000e+0	3.551378e+1	2.815808e-2	1	254	5.000000e-1	3.937008e-3	unnamed	CYP4F3
MSigDB Oncogenic Signatures	NFE2L2.V2	Genes up-regulated in MEF cells (embryonic fibroblasts) with knockout of NFE2L2 [Gene ID=4780] gene.	6	4.485003e-2	1.000000e+0	1.000000e+0	2.229653e+1	4.485003e-2	1	4.485003e-2	1.000000e+0	6	4.645297e-2	1.000000e+0	1.000000e+0	2.127476e+1	4.700405e-2	1	424	5.000000e-1	2.358491e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. pneumoniae infection.	1	9.386539e-3	1.000000e+0	1.000000e+0	1.065355e+2	9.386539e-3	1	9.386539e-3	1.000000e+0	3	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE6269_E_COLI_VS_STREP_AUREUS_INF_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute E. coli infection versus PBMC from patients with acute S. aureus infection.	2	1.064443e-2	1.000000e+0	1.000000e+0	9.394584e+1	1.064443e-2	1	1.064443e-2	1.000000e+0	10	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.	3	1.269901e-2	1.000000e+0	1.000000e+0	7.874632e+1	1.269901e-2	1	1.269901e-2	1.000000e+0	2	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_8H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 8 h versus those stimulated with poly(I:C) (TLR3 agonist) at 8 h.	4	1.343291e-2	1.000000e+0	1.000000e+0	7.444404e+1	1.343291e-2	1	1.343291e-2	1.000000e+0	26	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 12 h versus those stimulated with Gardiquimod (TLR7 agonist) at 12 h.	5	1.533954e-2	1.000000e+0	1.000000e+0	6.519101e+1	1.533954e-2	1	1.533954e-2	1.000000e+0	26	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	6	1.564725e-2	1.000000e+0	1.000000e+0	6.390901e+1	1.564725e-2	1	1.564725e-2	1.000000e+0	5	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE7764_NKCELL_VS_SPLENOCYTE_DN	Genes down-regulated in comparison of NK cells versus total splenocytes.	7	1.570732e-2	1.000000e+0	1.000000e+0	6.366460e+1	1.570732e-2	1	1.570732e-2	1.000000e+0	24	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those post-vaccination.	8	1.572806e-2	1.000000e+0	1.000000e+0	6.358062e+1	1.572806e-2	1	1.572806e-2	1.000000e+0	11	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_1H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with poly(I:C) (TLR3 agonist) at 1 h.	9	1.606339e-2	1.000000e+0	1.000000e+0	6.225335e+1	1.606339e-2	1	1.606339e-2	1.000000e+0	18	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE27786_LSK_VS_ERYTHROBLAST_DN	Genes down-regulated in comparison of LSK versus erythroblasts.	10	1.619171e-2	1.000000e+0	1.000000e+0	6.175999e+1	1.619171e-2	1	1.619171e-2	1.000000e+0	18	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	CYP4F22
MSigDB Immunologic Signatures	GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN	Genes down-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus those treated with 1 ng/ml LPS (TLR4 agonist).	11	1.670455e-2	1.000000e+0	1.000000e+0	5.986392e+1	1.670455e-2	1	1.670455e-2	1.000000e+0	1	1.688991e-2	1.000000e+0	1.000000e+0	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at the time of diagnosis.	12	1.686420e-2	1.000000e+0	1.000000e+0	5.929720e+1	1.686420e-2	1	1.686420e-2	1.000000e+0	12	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_24H_LPS_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus those stimulated at 24 h.	13	1.699059e-2	1.000000e+0	1.000000e+0	5.885610e+1	1.699059e-2	1	1.699059e-2	1.000000e+0	22	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_12H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 12 h versus those stimulated with CpG DNA (TLR9 agonist) at 12 h.	14	1.704319e-2	1.000000e+0	1.000000e+0	5.867445e+1	1.704319e-2	1	1.704319e-2	1.000000e+0	26	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 7 days after stimulation with YF17D vaccine.	15	1.725691e-2	1.000000e+0	1.000000e+0	5.794781e+1	1.725691e-2	1	1.725691e-2	1.000000e+0	9	1.864787e-2	1.000000e+0	1.000000e+0	5.337574e+1	1.873510e-2	1	169	5.000000e-1	5.917160e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from LAIV influenza vaccine pre-vaccination versus those at day 7 post-vaccination.	16	1.742304e-2	1.000000e+0	1.000000e+0	5.739526e+1	1.742304e-2	1	1.742304e-2	1.000000e+0	5	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 24 h versus those stimulated with Gardiquimod (TLR7 agonist) at 24 h.	17	1.793432e-2	1.000000e+0	1.000000e+0	5.575900e+1	1.793432e-2	1	1.793432e-2	1.000000e+0	24	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN	Genes down-regulated in comparison of B cells from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	18	1.809406e-2	1.000000e+0	1.000000e+0	5.526677e+1	1.809406e-2	1	1.809406e-2	1.000000e+0	12	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE3982_DC_VS_NEUTROPHIL_DN	Genes down-regulated in comparison of dendritic cells (DC) versus neutrophils.	19	1.811614e-2	1.000000e+0	1.000000e+0	5.519940e+1	1.811614e-2	1	1.811614e-2	1.000000e+0	32	2.248791e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_12H_LPS_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus those stimulated at 12 h.	20	1.814749e-2	1.000000e+0	1.000000e+0	5.510404e+1	1.814749e-2	1	1.814749e-2	1.000000e+0	17	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 12 h.	21	1.817131e-2	1.000000e+0	1.000000e+0	5.503180e+1	1.817131e-2	1	1.817131e-2	1.000000e+0	31	2.237830e-2	1.000000e+0	1.000000e+0	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_24H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 24 h versus those stimulated with CpG DNA (TLR9 agonist) at 24 h.	22	1.825466e-2	1.000000e+0	1.000000e+0	5.478054e+1	1.825466e-2	1	1.825466e-2	1.000000e+0	30	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 48 h.	23	1.849675e-2	1.000000e+0	1.000000e+0	5.406354e+1	1.849675e-2	1	1.849675e-2	1.000000e+0	12	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from LAIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.	24	1.874321e-2	1.000000e+0	1.000000e+0	5.335266e+1	1.874321e-2	1	1.874321e-2	1.000000e+0	4	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE27786_NKCELL_VS_ERYTHROBLAST_DN	Genes down-regulated in comparison of NK cells versus erythroblasts.	25	1.874606e-2	1.000000e+0	1.000000e+0	5.334455e+1	1.874606e-2	1	1.874606e-2	1.000000e+0	12	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	CYP4F22
MSigDB Immunologic Signatures	GSE17721_12H_VS_24H_CPG_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 12 h versus those stimulated with CpG DNA (TLR9 agonist) at 24 h.	26	1.913392e-2	1.000000e+0	1.000000e+0	5.226319e+1	1.913392e-2	1	1.913392e-2	1.000000e+0	22	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 0 h versus PMN treated with F. tularensis vaccine at 24 h.	27	1.928457e-2	1.000000e+0	1.000000e+0	5.185493e+1	1.928457e-2	1	1.928457e-2	1.000000e+0	18	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_LPS_0.5H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 0 h versus those stimulated with LPS (TLR4 agonist) at 0.5 h.	28	1.943415e-2	1.000000e+0	1.000000e+0	5.145581e+1	1.943415e-2	1	1.943415e-2	1.000000e+0	21	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) before vs after YF17D vaccination.	29	1.959575e-2	1.000000e+0	1.000000e+0	5.103148e+1	1.959575e-2	1	1.959575e-2	1.000000e+0	8	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP	Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells from young donors treated with TSST at 16 h versus those from old donors treated with TSST at 16 h.	30	1.966926e-2	1.000000e+0	1.000000e+0	5.084075e+1	1.966926e-2	1	1.966926e-2	1.000000e+0	12	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee before vaccination versus that after the vaccination.	31	2.036041e-2	1.000000e+0	1.000000e+0	4.911492e+1	2.036041e-2	1	2.036041e-2	1.000000e+0	7	1.820853e-2	1.000000e+0	1.000000e+0	5.466970e+1	1.829167e-2	1	165	5.000000e-1	6.060606e-3	unnamed	CYP4F3
MSigDB Immunologic Signatures	GSE22886_NEUTROPHIL_VS_MONOCYTE_UP	Genes up-regulated in comparison of neuthrophils versus monocytes.	32	2.306558e-2	1.000000e+0	1.000000e+0	4.335465e+1	2.306558e-2	1	2.306558e-2	1.000000e+0	26	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	CYP4F3
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
